Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

DNA damage repair capability assays are critical for evaluating genomic stability and understanding the mechanisms of carcinogenesis. These specialized tests provide valuable insights into cellular response to genotoxic stress, aiding researchers in drug development and personalized medicine. By quantifying the efficiency of DNA repair pathways, scientists can better assess disease risk and therapeutic outcomes.

DNA

Technical Overview

DNA damage is an inevitable phenomenon caused by both endogenous metabolic processes and exogenous environmental agents such as UV radiation and chemical toxins. The DNA damage repair capability assay is designed to quantify the efficiency of cellular repair mechanisms that maintain genomic integrity. These mechanisms include critical pathways such as Base Excision Repair (BER), Nucleotide Excision Repair (NER), Mismatch Repair (MMR), and Double-Strand Break (DSB) repair. By assessing the kinetics of damage removal or the residual damage levels, researchers can determine the resilience of cells against mutagenic threats.

Testing Samples

Peripheral Blood Mononuclear Cells

PBMCs are the most frequently used sample type for human clinical studies due to their accessibility. They provide a reliable source of primary cells to evaluate individual DNA repair phenotypes and assess susceptibility to environmental carcinogens or aging-related decline in repair capacity.

Cultured Cell Lines

Various mammalian and human cell lines are utilized for in vitro research. These samples are essential for high-throughput screening of pharmaceutical compounds intended to modulate DNA repair pathways or for testing the genotoxicity of new chemicals.

Tissue Biopsies

Fresh or frozen tissue samples, particularly tumor biopsies, are analyzed to understand the DNA repair status of specific tissues. This information helps in predicting patient response to radiotherapy or specific chemotherapeutic agents like platinum drugs.

Testing Items

The specific parameters analyzed depend on the research objectives and the type of DNA damage induced.

  • Quantification of DNA Single-Strand Breaks (SSB) and Double-Strand Breaks (DSB).
  • Measurement of Unscheduled DNA Synthesis (UDS) as an indicator of NER activity.
  • Detection of specific DNA adducts and their removal kinetics.
  • Expression levels and activity of key repair enzymes such as OGG1, PARP, and DNA-PK.
  • Phosphorylation status of histone H2AX (Gamma-H2AX) as a sensitive marker for DSB repair.

Testing Methods

Comet Assay (Single Cell Gel Electrophoresis)

The comet assay is a sensitive and versatile technique used to detect DNA strand breaks at the single-cell level. Under an electric field, fragmented DNA migrates away from the nucleus, forming a tail reminiscent of a comet, where the tail length and intensity correlate with the degree of damage. It can be adapted to detect specific types of damage using repair enzymes.

Gamma-H2AX Immunofluorescence

This method uses specific antibodies to detect phosphorylated histone H2AX, a highly sensitive marker for DNA double-strand breaks. By quantifying the number of fluorescent foci per nucleus, researchers can accurately track the formation and subsequent repair of DSBs over time.

Host Cell Reactivation Assay

This functional assay measures the ability of cells to repair a damaged reporter gene, typically a luciferase or GFP gene, which has been transfected into the cells. The restoration of gene expression indicates successful repair by the host cell machinery, often used to study NER or TCR pathways.

Applications

Assessment of DNA repair capacity has profound implications across multiple scientific and medical disciplines.

  • Oncology: Identifying cancer risk in predisposed individuals and predicting tumor response to therapies targeting DNA repair defects, such as PARP inhibitors.
  • Drug Development: Screening for compounds that either inhibit or enhance DNA repair pathways for therapeutic intervention.
  • Toxicology: Evaluating the genotoxic potential of industrial chemicals, cosmetics, and environmental pollutants to ensure safety compliance.
  • Aging Research: Investigating the correlation between declining DNA repair efficiency and the aging process or age-related degenerative diseases.

FAQ

Why is the DNA damage repair capability important?

Efficient DNA repair is crucial for preventing the accumulation of mutations that can lead to cancer, aging, and various genetic disorders. Measuring this capability helps assess genomic stability and disease susceptibility.

How long does a typical assay take?

The duration varies depending on the method used. A standard comet assay may take one to two days, while kinetic studies monitoring repair over time can span several days.

Can these tests be used for personalized medicine?

Yes, evaluating DNA repair capacity in patient samples can guide clinical decisions, particularly in selecting appropriate chemotherapy agents or predicting sensitivity to radiation therapy.